Cannara Biotech Inc (LOVE.V)
0.72
0.00 (0.00%)
CAD |
TSXV |
Jun 17, 16:00
Cannara Biotech Total Liabilities (Quarterly): 66.48M for Feb. 29, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | 66.48M |
November 30, 2023 | 62.96M |
August 31, 2023 | 61.78M |
May 31, 2023 | 60.40M |
February 28, 2023 | 57.37M |
November 30, 2022 | 58.14M |
August 31, 2022 | 58.88M |
May 31, 2022 | 42.65M |
February 28, 2022 | 39.15M |
November 30, 2021 | 38.62M |
August 31, 2021 | 27.91M |
Date | Value |
---|---|
May 31, 2021 | 21.43M |
February 28, 2021 | 19.97M |
November 30, 2020 | 16.54M |
August 31, 2020 | 16.49M |
May 31, 2020 | 16.27M |
February 29, 2020 | 15.39M |
November 30, 2019 | 14.64M |
August 31, 2019 | 18.17M |
May 31, 2019 | 17.36M |
February 28, 2019 | 22.71M |
November 30, 2018 | 0.0137M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
14.64M
Minimum
Nov 2019
66.48M
Maximum
Feb 2024
37.54M
Average
38.62M
Median
Nov 2021
Total Liabilities (Quarterly) Benchmarks
Biocure Technology Inc | 0.3992M |
Core One Labs Inc | 1.759M |
Nova Mentis Life Science Corp | 0.9951M |
Nanosphere Health Sciences Inc | 2.160M |
Lobe Sciences Ltd | 3.343M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 145.82M |
Shareholders Equity (Quarterly) | 79.34M |
Debt to Equity Ratio | 0.6136 |
Current Ratio | 0.969 |
Net Debt Paydown Yield | -0.15% |